FIG4 Antibody - BSA Free
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-84935
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit
Format
BSA Free
Concentration
0.5 mg/ml
Product Specifications
Immunogen
The immunogen is a synthetic peptide directed towards the C terminal region of human FIG4. Peptide sequence: PISAFSQDNIYEVQPPRVDRKSTEIFQAHIQASQGIMQPLGKEDSSMYRE The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Scientific Data Images for FIG4 Antibody - BSA Free
Western Blot: FIG4 Antibody [NBP2-84935]
Western Blot: FIG4 Antibody [NBP2-84935] - Host: Rabbit. Target Name: FIG4. Sample Tissue: Human Hela Whole Cell lysates. Antibody Dilution: 1ug/mlApplications for FIG4 Antibody - BSA Free
Application
Recommended Usage
Western Blot
1.0 ug/ml
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Format
BSA Free
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: FIG4
Alternate Names
ALS11polyphosphoinositide phosphatase, CMT4J, dJ249I4.1, EC 3.1.3, EC 3.1.3.-, EC 3.1.3.36, FIG4 homolog (S. cerevisiae), FIG4 homolog, SAC1 lipid phosphatase domain containing (S. cerevisiae), hSac3, KIAA0274FIG4 homolog, SAC domain containing lipid phosphatase, Phosphatidylinositol 3,5-bisphosphate 5-phosphatase, Sac domain-containing inositol phosphatase 3, SAC domain-containing protein 3, SAC3FIG4 homolog, SAC1 domain containing lipid phosphatase
Gene Symbol
FIG4
Additional FIG4 Products
Product Specific Notices for FIG4 Antibody - BSA Free
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...